Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Data Brief ; 13: 129-131, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28603757

ABSTRACT

The data presented in this article are related to the research article entitled "Child and adult exposure and health risk evaluation following the use of metal- and metalloid-containing costume cosmetics sold in the United States" [1]. This article describes the concentration of metals and metalloids contained in various cosmetic products such as body paint, lipstick and eye shadow, the relative percent deviation of two analyses performed on the products and the physico-chemico properties of the metals and metalloids used in the SkinPerm model presented in the aforementioned article.

2.
Regul Toxicol Pharmacol ; 84: 54-63, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28007419

ABSTRACT

Costume cosmetics (lipstick, body paints, eyeshadow) were analyzed for metals using inductively coupled plasma mass spectrometry (ICP-MS). Sb was detected in all samples (range: 0.12-6.3 mg/kg; d.f. 100%), followed by Pb (<0.15-9.3 mg/kg), Ni (<0.20-6.3 mg/kg), Co (<0.5-2.0 mg/kg); with d.f. 80% each, Hg (<0.00015-0.0020 mg/kg; d.f. 50%) and As (0.53 mg/kg, d.f. 10%). Ingestion and dermal exposures were estimated for child- and adult-intermittent and adult-occupational users. Adult-occupational users exceeded the U.S. EPA Reference Dose (RfD) for Sb and the CA Proposition 65 maximum allowable dose level (MADL) for Pb was exceeded for all user scenarios. The Pb dose from body paint was sufficient to raise blood lead levels (BLL) in all user scenarios above baseline BLLs from 0.2 µg/dL to 1.9 µg/dL per the Adult Lead Model (ALM) and child Integrated Exposure Uptake Biokinetic (IEUBK) blood Pb models. Change in BLL was less than 1 µg/dL amongst the child and adult-intermittent users, the benchmark change in BLL developed for health risk assessments for children. Adult-occupational users exceeded the CA Proposition 65 NSRL intake value of 15 µg/day, which corresponds to an increase of 1.2 µg/dL above baseline levels using ALM. Exposure of occupational users of costume cosmetics should be evaluated further to prevent unnecessary metal exposure.


Subject(s)
Cosmetics/analysis , Metalloids/analysis , Metals, Heavy/analysis , Administration, Cutaneous , Adult , Age Factors , Child , Consumer Product Safety , Cosmetics/adverse effects , Dose-Response Relationship, Drug , Heavy Metal Poisoning , Humans , Mass Spectrometry/methods , Maximum Allowable Concentration , Metalloids/adverse effects , Metalloids/blood , Metals, Heavy/adverse effects , Metals, Heavy/blood , Models, Biological , Occupational Diseases/chemically induced , Occupational Exposure/adverse effects , Occupations , Poisoning/etiology , Recreation , Risk Assessment , Risk Factors , Time Factors , United States
3.
PLoS One ; 8(2): e56764, 2013.
Article in English | MEDLINE | ID: mdl-23457612

ABSTRACT

We study the effect of isoforms of osteopontin (OPN) on the nucleation and growth of crystals from a supersaturated solution of calcium and phosphate ions. Dynamic light scattering is used to monitor the size of the precipitating particles and to provide information about their concentration. At the ion concentrations studied, immediate precipitation was observed in control experiments with no osteopontin in the solution, and the size of the precipitating particles increased steadily with time. The precipitate was identified as hydroxyapatite by X-ray diffraction. Addition of native osteopontin (nOPN) extracted from rat bone caused a delay in the onset of precipitation and reduced the number of particles that formed, but the few particles that did form grew to a larger size than in the absence of the protein. Recombinant osteopontin (rOPN), which lacks phosphorylation, caused no delay in initial calcium phosphate precipitation but severely slowed crystal growth, suggesting that rOPN inhibits growth but not nucleation. rOPN treated with protein kinase CK2 to phosphorylate the molecule (p-rOPN) produced an effect similar to that of nOPN, but at higher protein concentrations and to a lesser extent. These results suggest that phosphorylations are critical to OPN's ability to inhibit nucleation, whereas the growth of the hydroxyapatite crystals is effectively controlled by the highly acidic OPN polypeptide. This work also demonstrates that dynamic light scattering can be a powerful tool for delineating the mechanism of protein modulation of mineral formation.


Subject(s)
Durapatite/chemistry , Light , Osteopontin/pharmacology , Scattering, Radiation , Animals , Crystallization , Kinetics , Osteopontin/metabolism , Phosphorylation , Protein Isoforms/metabolism , Protein Isoforms/pharmacology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...